A
A

Price • Akari Therapeutics

AKTX

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Historical stock price chart and annual return over the past years

-96%

5 years

% Total

AKTX
-47%

5 years

Annual Return

AKTX